Balance Sheet Components

12 Months Ended

Dec. 31, 2022

Statement of Financial Position [Abstract]

Balance Sheet Components

. Balance Sheet Components

Property and equipment, net

Property and equipment, net consist of the following (in thousands):

	December 31,
	2022			2021
Laboratory equipment	$	2,661		$	1,734
Leasehold improvements		1,549			1,233
Software		104			60
Office equipment		157			42
Total		4,471			3,069
Less accumulated depreciation and amortization		(2,849	)		(2,331	)
Total		1,622			738
Construction-in-progress		4,416			3,874
Total property and equipment, net	$	6,038		$	4,612

Depreciation and amortization expense totaled approximately $0.5 million and $0.5 million for the years ended December 31, 2022 and 2021, respectively. As of December 31, 2022 and 2021, all of the Company’s property and equipment was located in the United States, respectively, with the exception of $3.5 million of construction-in-progress in 2021 that was located in Germany at a third-party manufacturing facility.

Accrued expenses

Accrued expenses consist of the following (in thousands):

	December 31,
	2022		2021
Accrued preclinical and clinical trial costs	$	1,130	$	621
Payroll and related		348		202
Accrued professional fees		165		213
Other		653		398
Total accrued expenses	$	2,296	$	1,434